Suchergebnisse - "Peng, Liubao"

PubPharm (88)

1

Cost-Effectiveness of Immune Checkpoint Inhibition and Targeted Treatment in Combination as Adjuvant Treatment of Patient with BRAF-Mutant Advanced Melanoma

enthalten in: ResearchSquare.com | 2023

von Li, S. | Wan, X. | Peng, L. | +2

2

Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced Breast Cancer in the United States

enthalten in: Clinical therapeutics | 2023

von Peng, Y. | Wang, L. | Peng, L. | +8

3

Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China : A Modeling Study

enthalten in: PharmacoEconomics | 2022

von Qin, S. | Wang, X. | Li, S. | +9

4

Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study

enthalten in: PharmacoEconomics | 2022

von Qin, S. | Wang, X. | Li, S. | +9

5

Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study

enthalten in: PharmacoEconomics | 2022

von Qin, S. | Wang, X. | Li, S. | +9

6

Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study

enthalten in: PharmacoEconomics | 2022

von Qin, S. | Wang, X. | Li, S. | +9

7

Sequences of biological treatments for patients with moderate-to-severe rheumatoid arthritis in the era of treat-to-target in China : a cost-effectiveness analysis

enthalten in: Clinical rheumatology | 2022

von Tan, C. | Luo, X. | Li, S. | +6

8

Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combined With Chemotherapy as First-Line Treatment for Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small Cell Lung Cancer

enthalten in: Frontiers in pharmacology | 2022

von Luo, X. | Liu, Q. | Zhou, Z. | +6

9

Cost-effectiveness of ensartinib, crizotinib, ceritinib, alectinib, brigatinib and lorlatinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer in China

enthalten in: Frontiers in public health | 2022

von Luo, X. | Zhou, Z. | Zeng, X. | +2

10

Comparative efficacy of various CHIs combined with western medicine for non-small cell lung cancer : A bayesian network meta-analysis of randomized controlled trials

enthalten in: Frontiers in pharmacology | 2022

von Peng, C. | Chen, J. | Cui, W. | +3

1
2
3
4
5
6
7
8
9
Nächster »
[9]